SUPPLEMENTATION WITH SELENIUM AND HUMAN IMMUNE CELL FUNCTIONS .2. EFFECT ON CYTOTOXIC LYMPHOCYTES AND NATURAL-KILLER-CELLS

被引:196
作者
KIREMIDJIANSCHUMACHER, L
ROY, M
WISHE, HI
COHEN, MW
STOTZKY, G
机构
[1] NYU, CTR DENT, DEPT ORAL MED & PATHOL, 550 1ST AVE, NEW YORK, NY 10010 USA
[2] NYU, CTR DENT, DEPT HISTOL & CELL BIOL, NEW YORK, NY 10010 USA
[3] NYU, DEPT BIOL, NEW YORK, NY 10003 USA
关键词
SELENIUM; HUMAN; IMMUNOENHANCEMENT; NK CELLS; CYTOTOXIC LYMPHOCYTES;
D O I
10.1007/BF02917222
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study examined the effect of dietary (200 mu g/d for 8 wk) supplementation with selenium (as sodium selenite) on the ability of human peripheral blood lymphocytes to respond to stimulation with alloantigen, develop into cytotoxic lymphocytes, and to destroy tumor cells, and on the activity of natural killer cells. The participants in the study were randomized for age, sex, weight, height, and nutritional habits and given selenite or placebo tablets; all participants had a selenium replete status as indicated by their plasma Se levels prior to supplementation. The data indicated that the supplementation regimen resulted in 118% increase in cytotoxic lymphocyte-mediated tumor cytotoxicity and 82.3% increase in natural killer cell activity as compared to baseline values. This apparently was related to the ability of the nutrient to enhance the expression of receptors for the growth regulatory lymphokine interleukin-2 and consequently, the rate of cell proliferation and differentiation into cytotoxic cells. The supplementation regimen did not produce significant changes in the plasma Se levels of the participants. The results indicated that the immunoenhancing effects of selenium in humans require supplementation above the replete levels produced by normal dietary intake.
引用
收藏
页码:115 / 127
页数:13
相关论文
共 36 条
[1]  
BEILSTEIN MA, 1987, SELENIUM BIOL MED A, P197
[2]   CELLULAR CYTOTOXICITY ASSESSED BY THE CR-51 RELEASE ASSAY - BIOLOGICAL INTERPRETATION OF MATHEMATICAL PARAMETERS [J].
BOL, SJ ;
ROSDORFF, HJ ;
RONTELTAP, CP ;
HENNEN, LA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 90 (01) :15-23
[3]  
BRENNER BG, 1985, CANCER, V56, P1543, DOI 10.1002/1097-0142(19851001)56:7<1543::AID-CNCR2820560713>3.0.CO
[4]  
2-K
[5]   SELENIUM AND CANCER - MEANING OF SERUM SELENIUM LEVELS [J].
BURK, RF .
JOURNAL OF NUTRITION, 1986, 116 (08) :1584-1586
[6]   TRANSIENT EXPRESSION OF INTERLEUKIN-2 RECEPTORS - CONSEQUENCES FOR T-CELL GROWTH [J].
CANTRELL, DA ;
SMITH, KA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (06) :1895-1911
[7]   IMMUNOTHERAPY WITH SENSITIZED LYMPHOCYTES [J].
CHANG, AE ;
SHU, S .
CANCER INVESTIGATION, 1992, 10 (05) :357-369
[8]   INTERLEUKIN-2 SIGNAL TRANSDUCTION IN HUMAN NK CELLS - MULTISITE PHOSPHORYLATION AND ACTIVATION OF THE TYROSINE KINASE P56LCK [J].
EINSPAHR, KJ ;
ABRAHAM, RT ;
DICK, CJ ;
LEIBSON, PJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 52 (05) :565-571
[9]   INTERLEUKIN-2 AUGMENTS NATURAL-KILLER CELL-ACTIVITY [J].
HENNEY, CS ;
KURIBAYASHI, K ;
KERN, DE ;
GILLIS, S .
NATURE, 1981, 291 (5813) :335-338
[10]   THE SELENITE-EXCHANGEABLE METABOLIC POOL IN HUMANS - A NEW CONCEPT FOR THE ASSESSMENT OF SELENIUM STATUS [J].
JANGHORBANI, M ;
MARTIN, RF ;
KASPER, LJ ;
SUN, XF ;
YOUNG, VR .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1990, 51 (04) :670-677